Emalex Biosciences has a total of 55 patents globally, out of which 35 have been granted. Of these 55 patents, more than 92% patents are active. Israel is where Emalex Biosciences has filed the maximum number of patents, followed by Japan. Parallelly, United States of America is the origin country
Verseau Therapeutics has a total of 75 patents globally, out of which none have been granted. Of these 75 patents, more than 90% patents are active. Europe (EPO) is where Verseau Therapeutics has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D
Rivus Pharmaceuticals has a total of 45 patents globally, out of which 25 have been granted. Of these 45 patents, more than 95% patents are active. The USA is where Rivus Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the United States seems
Woolsey Pharmaceuticals has a total of 59 patents globally, out of which 4 have been granted. Of these 59 patents, more than 98% patents are active. The USA is where Woolsey Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Canada. Parallelly, the United States seems
Obsidian Therapeutics has a total of 127 patents globally, out of which 7 have been granted. Of these 127 patents, more than 81% patents are active. The USA is where Obsidian Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and Hong Kong. Parallelly, the US seems
Mint Innovation has a total of 29 patents globally, out of which 11 have been granted. Of these 29 patents, more than 89% patents are active. Europe (EPO) and Australia among others is where Mint Innovation has filed the maximum number of patents. Parallelly, New Zealand seems to be the
Nuritas has a total of 136 patents globally, out of which 32 have been granted. Of these 136 patents, more than 80% patents are active. Europe (EPO) is where Nuritas has filed the maximum number of patents, followed by United States of America and South Korea. Parallelly, Europe (EPO) seems
Tulavi Therapeutics has a total of 40 patents globally, out of which 5 have been granted. Of these 40 patents, more than 92% patents are active. The United States of America is where Tulavi Therapeutics has filed the maximum number of patents, followed by Australia and Canada. Parallelly, the United
Visus Therapeutics has a total of 68 patents globally, out of which 10 have been granted. Of these 68 patents, more than 66% patents are active. The United States of America is where Visus Therapeutics has filed the maximum number of patents, followed by Europe. Parallelly, United States of America
Diagnose Early has a total of 15 patents globally, out of which 2 have been granted. Of these 15 patents, more than 86% patents are active. The USA is where Diagnose Early has filed the maximum number of patents, followed by Canada & Europe (EPO). Parallelly, the United States seems
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.